Adams Diversified Equity Fund’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-1,700
Closed -$146K – 173
2019
Q2
$146K Sell
1,700
-1,000
-37% -$68.2K 0.01% 138
2019
Q1
$160K Buy
+2,700
New +$155K 0.01% 214
2018
Q1
– Sell
-13,100
Closed -$475K – 224
2017
Q4
$475K Sell
13,100
-3,800
-22% -$138K 0.03% 198
2017
Q3
$648K Sell
16,900
-600
-3% -$25.1K 0.04% 203
2017
Q2
$725K Sell
17,500
-3,300
-16% -$125K 0.04% 185
2017
Q1
$732K Buy
20,800
+600
+3% +$19K 0.04% 199
2016
Q4
$623K Buy
+20,200
New +$625K 0.04% 205

Other funds holding RGEN

Adams Diversified Equity Fund's RGEN Position: Q3 2019 in Review

Adams Diversified Equity Fund sold out of Repligen (RGEN) in Q3 2019, closing a stake of 1,700 shares — an estimated $146K sold.

Adams Diversified Equity Fund first reported a position in RGEN in Q4 2016 and held it in 7 quarters. The position peaked at $732K in Q1 2017. 303 funds tracked by Wall St. Rank hold RGEN as of Q3 2019.

  • Adams Diversified Equity Fund reported no remaining Repligen position as of Q3 2019 after selling out during the quarter.
  • Adams Diversified Equity Fund sold 1,700 Repligen shares in Q3 2019, an estimated $146K.
  • Adams Diversified Equity Fund first reported a position in Repligen in Q4 2016 and held it in 7 quarters.
  • Adams Diversified Equity Fund's Repligen position peaked at $732K in Q1 2017.
  • 303 funds tracked by Wall St. Rank held Repligen as of Q3 2019.

Based on Adams Diversified Equity Fund's 13F filing for Q3 2019, filed 28 Oct 2019.